Meet Inspiring Speakers and Experts at our 3000+ Global Conference Series Events with over 1000+ Conferences, 1000+ Symposiums
and 1000+ Workshops on Medical, Pharma, Engineering, Science, Technology and Business.Explore and learn more about Conference Series : World's leading Event Organizer
As per available reports about 17 Conferences, 74 Workshops and 9 Relevant Journals 1699 conference proceedings are presently dedicated exclusively to Toxicity Assessment and about 471 articles are being published on Toxicity Assessment.
Toxicity assessment is mainly used to evaluate the available evidence regarding the potential of specific chemical substances which cause adverse effects in the individuals exposed. It also gives the relationship between the extent of exposure and its effects accordingly.
OMICS International Organizes 1000+ Global Events Every Year across USA, Europe & Asia with support from 1000 more scientific societies and Publishes 700+ Open access journals which contains over 100000 eminent personalities, reputed scientists as editorial board and organizing committee members. The conference series website will provide you list and details about the conference organize worldwide.
OMICS International Conference Series focuses to enhance knowledge dissemination among its varied range of participants including eminent speakers, renowned scientists, industrialists from top notch companies, young researchers and students. OMICS International Pharma conferences foster the better understanding of latest scientific researches by providing a global exposure to its participants where they can associate with relatable professionals. The scope of these gatherings is further extended by encompassing remarking key areas like Pharmaceutical Regulatory Affairs, Mass Spectrometry, Separation Techniques, Toxicology , Therapeutic Drug Monitoring and Toxicogenomics, Pain Medicine, Clinical Pharmacy, GMP and GLP quality control, followed by Bioavailability and Bioequivalence studies, Biosimilars and Pharmacognosy
Scope and Importance:
The toxicity assessment process is usually divided into two parts: the first characterizes and quantifies the non-cancer effects of the chemical, while the second addresses the cancer effects of the chemical. This two-part approach is employed because there are typically major differences in the time-course of action and the shape of the dose-response curve for cancer and non-cancer effects. Toxicity assessment is an integral part of the overall Superfund site risk assessment. Although toxicity information is critical to the risk assessment, the amount of new toxicological evaluation of primary data required to complete this step is limited in most cases. EPA has performed the toxicity assessment step for numerous chemicals and has made available the resulting toxicity information and toxicity values, which have undergone extensive peer review. At some sites, however, there will be significant data analysis and interpretation issues that should be addressed by an experienced toxicologist.
The conference on Toxicity assessment allows a scope for physicians, pharmacists, nurses, and scientists from around the world to participate in the sharing of knowledge on a wide variety of toxicity assessment topics and issues. In addition, there will be presentation of research papers, a number of symposia, as well as other traditional and novel continuing education sessions. .
Market Analysis:
An overview of the global toxicity testing market is obtained by analyses of market trends. The two major technology-based approaches utilised are mechanistic and nonmechanistic
In 2011, the global in vitro toxicity testing market was valued at $4 billion and more than $4.9 billion in 2012. This is estimated to reach around $9.9 billion in 2017, with a compound annual growth rate (CAGR) of 14.7% for the five-year period, 2012 to 2017.
Influential factors for this estimation are alternative measures for toxicity and toxicity testing, validation of the techniques for chemicals, pesticides, and food additives.
A significant share of 32% is taken up by the pharmaceutical arena which is valued at $424 million in 2010. This sector is estimated to reach a value of $976 million, at a compound annual growth rate (CAGR) of 18.2%. by 2015.
List of Best International Conferences:
Societies:
Related Companies:
This page will be updated regularly.
This page was last updated on November 5, 2024
